Endo Pharmaceuticals, Inc. FDA Recalls

2 recalls on file across drugs, 1 of them Class I and 0 still open. This firm is not matched to a listed company.

Newest first

Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.

Product	Reason	Class	Initiated
Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.125mg, 60 tablets per carton (10 blister cards containing 6 tableClass IJul 10, 2024Labeling: Label Error on Declared Strength; Some cartons wer	Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25	Class IDrugs	Jul 10, 2024
Calcitonin Salmon Nasal Spray, USP, 2200 International Units per mL corresponding to 200 International Units/spray, 3.7 Class IIMar 2, 2023Failed Impurities/Degradation Specifications and Subpotent D	Failed Impurities/Degradation Specifications and Subpotent Drug: High Out of Specification results for a known	Class IIDrugs	Mar 2, 2023